日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prevalence of Antibodies to Japanese Encephalitis Virus and Severe Fever with Thrombocytopenia Syndrome Virus in Wild Boars Captured Across Different Locations in Toyama Prefecture, Japan

日本富山县不同地区捕获的野猪体内日本脑炎病毒和发热伴血小板减少综合征病毒抗体的流行情况

Yazawa, Shunsuke; Yoshida, Kotoha; Fujii, Kotaro; Saga, Yumiko; Taniguchi, Sara; Suzuki, Ryosuke; Lim, Chang-Kweng; Ishida, Miki; Oishi, Kazunori; Tani, Hideki

Successful 30-Day Nirmatrelvir/Ritonavir Treatment of a Patient Who Developed Multi-relapsed COVID-19 After Receiving R-CHOP Against Follicular Lymphoma

接受 R-CHOP 方案治疗滤泡性淋巴瘤后出现多次 COVID-19 复发的患者,经 30 天尼马替韦/利托那韦治疗后获得成功

Kimoto, Kou; Kawasuji, Hitoshi; Yoshida, Yoshihiro; Yamada, Hiroshi; Yazawa, Shunsuke; Tani, Hideki; Koshiyama, Yuki; Nabe, Yoshimi; Kikuchi, Shohei; Nagaoka, Kentaro; Morinaga, Yoshitomo; Yamamoto, Yoshihiro

High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection

COVID-19肺炎诱导的高白细胞介素-6水平与循环滤泡辅助性T细胞频率增加以及Omicron突破性感染急性期强烈的抗体中和反应相关。

Kawasuji, Hitoshi; Morinaga, Yoshitomo; Nagaoka, Kentaro; Tani, Hideki; Yoshida, Yoshihiro; Yamada, Hiroshi; Takegoshi, Yusuke; Kaneda, Makito; Murai, Yushi; Kimoto, Kou; Niimi, Hideki; Yamamoto, Yoshihiro

COVID-19 mRNA booster vaccination induces robust antibody responses but few adverse events among SARS-CoV-2 naïve nursing home residents

新冠病毒mRNA加强疫苗可在未感染过SARS-CoV-2的养老院居民中诱导产生强烈的抗体反应,但不良反应较少。

Itamochi, Masae; Yazawa, Shunsuke; Saga, Yumiko; Shimada, Takahisa; Tamura, Kosuke; Maenishi, Emi; Isobe, Junko; Sasajima, Hitoshi; Kawashiri, Chikako; Tani, Hideki; Oishi, Kazunori

Association between sore throat and early immune responses against COVID-19 before and after the emergence of the Omicron variant

在 Omicron 变异株出现前后,咽喉痛与针对 COVID-19 的早期免疫反应之间存在关联

Takegoshi, Yusuke; Nagaoka, Kentaro; Kido, Toshiki; Kawasuji, Hitoshi; Murai, Yushi; Kaneda, Makito; Kimoto, Kou; Tani, Hideki; Niimi, Hideki; Morinaga, Yoshitomo; Yamamoto, Yoshihiro

SARS-CoV-2 Variants and Age-Dependent Infection Rates among Household and Nonhousehold Contacts

SARS-CoV-2 变异株及家庭和非家庭接触者中与年龄相关的感染率

Miyahara, Reiko; Tamura, Kosuke; Kato, Tomoko; Nakazaki, Mineko; Otani, Kanako; Ko, Yura K; Kamigaki, Taro; Arima, Yuzo; Tani, Hideki; Oishi, Kazunori; Suzuki, Motoi

Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5

野生型/Omicron BA.1二价疫苗作为第二剂加强针对Omicron BA.2和BA.5的中和抗体反应

Kawasuji, Hitoshi; Morinaga, Yoshitomo; Tani, Hideki; Saga, Yumiko; Yamada, Hiroshi; Yoshida, Yoshihiro; Takegoshi, Yusuke; Kaneda, Makito; Murai, Yushi; Kimoto, Kou; Ueno, Akitoshi; Miyajima, Yuki; Nagaoka, Kentaro; Ono, Chikako; Matsuura, Yoshiharu; Niimi, Hideki; Yamamoto, Yoshihiro

Long-Term Detection and Isolation of Severe Fever with Thrombocytopenia Syndrome (SFTS) Virus in Dog Urine

犬尿中发热伴血小板减少综合征(SFTS)病毒的长期检测与分离

Saga, Yumiko; Yoshida, Toshikazu; Yoshida, Rieko; Yazawa, Shunsuke; Shimada, Takahisa; Inasaki, Noriko; Itamochi, Masae; Yamazaki, Emiko; Oishi, Kazunori; Tani, Hideki

Dominant CT Patterns and Immune Responses during the Early Infection Phases of Different SARS-CoV-2 Variants

不同SARS-CoV-2变种早期感染阶段的主要CT模式和免疫反应

Nagaoka, Kentaro; Kawasuji, Hitoshi; Takegoshi, Yusuke; Murai, Yushi; Kaneda, Makito; Kimoto, Kou; Tani, Hideki; Niimi, Hideki; Morinaga, Yoshitomo; Noguchi, Kyo; Yamamoto, Yoshihiro

Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort

日本养老院人群中,新冠mRNA疫苗加强剂对Omicron亚型BA.1和BA.5的中和作用

Itamochi, Masae; Yazawa, Shunsuke; Inasaki, Noriko; Saga, Yumiko; Yamazaki, Emiko; Shimada, Takahisa; Tamura, Kosuke; Maenishi, Emi; Isobe, Junko; Nakamura, Masahiko; Takaoka, Misuzu; Sasajima, Hitoshi; Kawashiri, Chikako; Tani, Hideki; Oishi, Kazunori